scholarly journals Evaluation of rapid response team implementation in medical emergencies: A gallant evidence based medicine initiative in developing countries for serious adverse events

2014 ◽  
Vol 4 (1) ◽  
pp. 3 ◽  
Author(s):  
Mohammed Imran ◽  
Yash Javeri ◽  
Monika Rajani ◽  
Shadab Samad ◽  
Omender Singh ◽  
...  
Keyword(s):  
Developing Countries ◽  
Adverse Events ◽  
Evidence Based Medicine ◽  
Rapid Response Team ◽  
Rapid Response ◽  
Evidence Based ◽  
Serious Adverse Events ◽  
Response Team ◽  
Medical Emergencies ◽  
Based Medicine

scholarly journals Evidence-based Medicine and Rapid Response Team Implementation

2020 ◽  
Vol 9 (1) ◽  
Author(s):  
Jeffrey Bruckel
Keyword(s):  
Blood Pressure ◽  
Rapid Response Team ◽  
Rapid Response ◽  
Evidence Based ◽  
Confounding Factors ◽  
Organizational Changes ◽  
Rapid Response Teams ◽  
Response Team ◽  
Based Medicine ◽  
Acute Care Unit

The implementation of Rapid Response Teams is becoming commonplace in U.S. hospitals, following the model developed in Australia. The Rapid Response Team is a method of bringing ICU-level patient care to the bedside of critically ill patients using a multidisciplinary team. Acute care unit staff are trained to recognize clinical deterioration using a set of vital sign calling criteria (systolic blood pressure below 90 mmHg, pulse below 60 or above 100, etc.). Many hospitals have been facing problems gaining needed support to make the organizational changes needed for the team to function properly. Some faculty physicians have expressed apprehension about losing control over their patients, and they have also highlighted the lack of rigorous experimental evidence that the teams work. Since there are so many confounding factors at work when trying to design an experimental study of this type of change, the study may not accurately portray the situation. Other evaluation methods should therefore be considered.

scholarly journals Construction of Clinical Pathway Information Management System under the Guidance of Evidence-Based Medicine

2021 ◽  
Vol 2021 ◽  
pp. 1-12
Author(s):  
Xinyu Wang ◽  
Jie Chen ◽  
Fang Peng ◽  
Jingtai Lu
Keyword(s):  
Adverse Events ◽  
Information Management ◽  
Clinical Pathway ◽  
Evidence Based Medicine ◽  
Medical Staff ◽  
Management System ◽  
Information Management System ◽  
Evidence Based ◽  
Work Efficiency ◽  
Based Medicine

This study focuses on clinical pathways guided by evidence-based medicine (EBM). With the clinical pathway as the center, the subjective and objective medical knowledge of medical staff are collected, and a clinical pathway management system guided by EBM is established through a unified process; user demand analysis; main considerations; implementation, evaluation, and monitoring of the clinical path; and dictionary maintenance, to help hospitals fully regulate medical behaviors. Next, the study displays the path access prompt box, area 1 management page, table management page, exit prompt box, mutation record page, doctor order interface, revocation of execution, and monitoring interface, and the system designed is compared with the Beijing Shankang Technology (ASK) clinical data management system in terms of user experience. The results showed that the reporting rate of medical adverse events in the system in this study was 0.21%, and the work efficiency was increased by 14%. In terms of users’ satisfaction, the hospital managers’ satisfaction was 84 ± 5.36%, and it was 95 ± 4.72% for medical staff and 88 ± 4.91% for system administrators, superior to the ASK system; the differences were statistically significant ( P < 0.05 ). In conclusion, the clinical pathway information management system is in line with the working environment of medical staff, and the synchronous monitoring and management of medical quality are achieved through digital means, which can reduce the occurrence of medical adverse events and improve the work efficiency of medical staff.

scholarly journals Rapid Response: Ivermectin in Covid-19

2021 ◽  
Author(s):  
Andrew Bryant ◽  
Theresa A Lawrie ◽  
Edmund Fordham ◽  
Mitchell Scott
Keyword(s):  
Evidence Based Medicine ◽  
Rapid Response ◽  
Evidence Based ◽  
Original Letter ◽  
Rapid Responses ◽  
Based Medicine

Rapid Response to BMJ Evidence-Based Medicine re Popp et al., Letter to Editor, DOI: 10.1136/bmjebm-2021-111791. Rapid Responses appear as tabs to the original Letter but do not acquire DOI references. This posting provides a DOI to the text of the Rapid Response and a clear text with errors of formatting in the journal version repaired.

Sense and non-sense of polypharmacy: increasing efficacy, decreasing compliance?

2003 ◽  
Vol 18 (S2) ◽  
pp. 54s-61s ◽  
Author(s):  
Patrice Boyer
Keyword(s):  
Side Effects ◽  
Adverse Events ◽  
Evidence Based Medicine ◽  
Symptom Control ◽  
Single Agent ◽  
Effective Control ◽  
Evidence Based ◽  
Drug Classes ◽  
Psychotropic Agents ◽  
Based Medicine

The objective in managing patients with schizophrenia is to provide effective control of symptoms and enable the patient to reintegrate into society. Pharmacotherapy should, therefore, aim to provide optimum symptom control with minimal side effects using a simple dosage regimen. Ideally, this would be achieved through the use of a single agent. Some patients are successfully managed with a single antipsychotic drug, but it is often necessary or thought to be necessary to use a combination of agents to provide effective treatment. One European survey reported that most patients receive two to three psychotropic agents on average, but at least 5-22% receive five or more agents [53]. Unfortunately, the addition of more agents increases the risk of drug interactions, adverse events and non-compliance. This is amplified by the paucity of evidence-based medicine currently available to guide physicians in the use of combinations of agents, and the tendency of polypharmaceutical practice to be mostly driven by personal preference, clinical experience and marketing. This article therefore briefly looks at the feasibility of using various drug classes as adjunctive therapy in patients with schizophrenia.

Sign in / Sign up

Export Citation Format

Share Document